Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 907 word(s) 907 2020-12-15 07:20:32

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Tang, P. CFEOM. Encyclopedia. Available online: (accessed on 25 April 2024).
Tang P. CFEOM. Encyclopedia. Available at: Accessed April 25, 2024.
Tang, Peter. "CFEOM" Encyclopedia, (accessed April 25, 2024).
Tang, P. (2021, January 04). CFEOM. In Encyclopedia.
Tang, Peter. "CFEOM." Encyclopedia. Web. 04 January, 2021.

Congenital fibrosis of the extraocular muscles (CFEOM) is a disorder of the nervous system that affects use of the muscles that surround the eyes (extraocular muscles). These muscles control eye movement and the direction of the eyes (for example, looking straight ahead). CFEOM impairs control of these muscles. As a result, affected individuals are unable to move their eyes normally. Most people with this condition have difficulty looking upward, and their side-to-side eye movement may also be limited. The eyes may look in different directions (strabismus). Instead of moving their eyes, affected individuals may need to turn their head to track moving objects. Additionally, most people with CFEOM have droopy eyelids (ptosis), which further limits their vision.

genetic conditions

1. Introduction

Researchers have identified several forms of CFEOM, designated CFEOM1, CFEOM2, CFEOM3, and Tukel syndrome (sometimes called CFEOM4). The specific problems with eye movement vary among the types, and some types are associated with additional signs and symptoms. People with CFEOM1 and CFEOM2 have only the eye problems described above. In CFEOM1, the eyes typically point downward, whereas in CFEOM2, the eyes usually turn outward.

CFEOM3 can include additional neurological problems, such as intellectual disability; difficulty with social skills; a smaller-than-normal head size (microcephaly); muscle weakness in the face; nonfunctioning vocal cords; and a set of symptoms called Kallmann syndrome, which features delayed or absent puberty and an impaired sense of smell. Some affected individuals develop pain, weakness, or a decreased ability to feel sensations in the limbs (peripheral neuropathy), which can begin in childhood or adulthood.

Brain abnormalities can also occur in people with CFEOM3. Some have abnormal development of the white matter, which is brain tissue containing nerve cell fibers (axons) that transmit nerve impulses. A particular form of CFEOM3, known as CFEOM3 with polymicrogyria, is characterized by abnormal development of the brain, in which the folds and ridges on the surface of the brain are smaller and more numerous than usual.

Tukel syndrome is characterized by missing fingers (oligodactyly) and other hand abnormalities in addition to problems with eye movement.

2. Frequency

CFEOM1 is the most common form of congenital fibrosis of the extraocular muscles, affecting at least 1 in 230,000 people. CFEOM1 and CFEOM3 have been reported worldwide, whereas CFEOM2 has been seen in only a few families of Turkish, Saudi Arabian, and Iranian descent. Tukel syndrome appears to be very rare; it has been diagnosed in only one large Turkish family.

3. Causes

Several genes involved in CFEOM have been identified. Mutations in the KIF21A gene cause CFEOM1 and rare cases of CFEOM3; mutations in the TUBB3 gene cause CFEOM3 and rare cases of CFEOM1; a mutation in the TUBB2B gene causes CFEOM3 with polymicrogyria; and mutations in the PHOX2A gene cause CFEOM2. The genetic cause of Tukel syndrome is unknown. The CFEOM-related genes are important for growth or development of nerve cells (neurons).

Mutations in the KIF21A, TUBB3, or TUBB2B gene impair a process called axon guidance. Through this process, the specialized extensions of neurons (axons) are directed to their correct positions. Once in the right position, axons relay messages from the brain to muscles and sensory cells and back to the brain, which is critical for controlling muscle movement and detecting sensations such as touch, pain, and heat. As a result of these mutations, axons do not reach their proper locations. Nerves in the head and face (known as cranial nerves) that control muscles that move the eyes and eyelids are particularly affected, although other nerves can also be involved. Abnormal growth of cranial nerves impairs extraocular muscle function and leads to the characteristic features of CFEOM, including restricted eye movement and droopy eyelids. Problems with other nerves likely underlie additional neurological features in people with CFEOM3.

The protein produced from the PHOX2A gene is involved in neuron development, particularly of cranial nerves III and IV, which are necessary for normal eye movement. Mutations likely eliminate the function of the PHOX2A protein, which prevents the normal development of these cranial nerves and impairs control of the extraocular muscles.

Studies suggest that a gene associated with Tukel syndrome may be located near one end of chromosome 21. Some people with features of CFEOM do not have mutations in the genes mentioned above, indicating that other genes that have not been identified may also be involved in the condition.

4. Inheritance

The different types of CFEOM have different patterns of inheritance. CFEOM1 and CFEOM3 are inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In some cases, an affected person inherits the mutation from one affected parent. Other cases result from new mutations in the gene and occur in people with no history of the disorder in their family.

CFEOM2 is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition. Tukel syndrome also appears to have an autosomal recessive pattern of inheritance, although the genetic change responsible for this disorder is unknown.

5. Other Names for This Condition

  • congenital external ophthalmoplegia
  • congenital fibrosis of extraocular muscles
  • congenital fibrosis syndrome
  • general fibrosis syndrome


  1. Bosley TM, Oystreck DT, Robertson RL, al Awad A, Abu-Amero K, Engle EC.Neurological features of congenital fibrosis of the extraocular muscles type 2with mutations in PHOX2A. Brain. 2006 Sep;129(Pt 9):2363-74.
  2. Cederquist GY, Luchniak A, Tischfield MA, Peeva M, Song Y, Menezes MP, ChanWM, Andrews C, Chew S, Jamieson RV, Gomes L, Flaherty M, Grant PE, Gupta ML Jr,Engle EC. An inherited TUBB2B mutation alters a kinesin-binding site and causespolymicrogyria, CFEOM and axon dysinnervation. Hum Mol Genet. 2012 Dec15;21(26):5484-99. doi: 10.1093/hmg/dds393.
  3. Demer JL, Clark RA, Engle EC. Magnetic resonance imaging evidence forwidespread orbital dysinnervation in congenital fibrosis of extraocular musclesdue to mutations in KIF21A. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):530-9.
  4. Heidary G, Engle EC, Hunter DG. Congenital fibrosis of the extraocularmuscles. Semin Ophthalmol. 2008 Jan-Feb;23(1):3-8. doi:10.1080/08820530701745181. Review.
  5. Lu S, Zhao C, Zhao K, Li N, Larsson C. Novel and recurrent KIF21A mutations incongenital fibrosis of the extraocular muscles type 1 and 3. Arch Ophthalmol.2008 Mar;126(3):388-94. doi: 10.1001/archopht.126.3.388.
  6. Nakano M, Yamada K, Fain J, Sener EC, Selleck CJ, Awad AH, Zwaan J, MullaneyPB, Bosley TM, Engle EC. Homozygous mutations in ARIX(PHOX2A) result incongenital fibrosis of the extraocular muscles type 2. Nat Genet. 2001Nov;29(3):315-20.
  7. Price JM, Boparai RS, Wasserman BN. Congenital fibrosis of the extraocularmuscles: review of recent literature. Curr Opin Ophthalmol. 2019Sep;30(5):314-318. doi: 10.1097/ICU.0000000000000592. Review.
  8. Tischfield MA, Baris HN, Wu C, Rudolph G, Van Maldergem L, He W, Chan WM,Andrews C, Demer JL, Robertson RL, Mackey DA, Ruddle JB, Bird TD, Gottlob I, PiehC, Traboulsi EI, Pomeroy SL, Hunter DG, Soul JS, Newlin A, Sabol LJ, Doherty EJ, de Uzcátegui CE, de Uzcátegui N, Collins ML, Sener EC, Wabbels B, Hellebrand H,Meitinger T, de Berardinis T, Magli A, Schiavi C, Pastore-Trossello M, Koc F,Wong AM, Levin AV, Geraghty MT, Descartes M, Flaherty M, Jamieson RV, Møller HU, Meuthen I, Callen DF, Kerwin J, Lindsay S, Meindl A, Gupta ML Jr, Pellman D,Engle EC. Human TUBB3 mutations perturb microtubule dynamics, kinesininteractions, and axon guidance. Cell. 2010 Jan 8;140(1):74-87. doi:10.1016/j.cell.2009.12.011.
  9. Tukel T, Uzumcu A, Gezer A, Kayserili H, Yuksel-Apak M, Uyguner O, GultekinSH, Hennies HC, Nurnberg P, Desnick RJ, Wollnik B. A new syndrome, congenitalextraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter.J Med Genet. 2005 May;42(5):408-15. Erratum in: J Med Genet. 2005 Nov;42(11):862.
  10. van der Vaart B, van Riel WE, Doodhi H, Kevenaar JT, Katrukha EA, Gumy L,Bouchet BP, Grigoriev I, Spangler SA, Yu KL, Wulf PS, Wu J, Lansbergen G, vanBattum EY, Pasterkamp RJ, Mimori-Kiyosue Y, Demmers J, Olieric N, Maly IV,Hoogenraad CC, Akhmanova A. CFEOM1-associated kinesin KIF21A is a corticalmicrotubule growth inhibitor. Dev Cell. 2013 Oct 28;27(2):145-160. doi:10.1016/j.devcel.2013.09.010.
  11. Whitman M, Hunter DG, Engle EC. Congenital Fibrosis of the ExtraocularMuscles. 2004 Apr 27 [updated 2016 Jan 14]. In: Adam MP, Ardinger HH, Pagon RA,Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet].Seattle (WA): University of Washington, Seattle; 1993-2020. Available from
  12. Yamada K, Andrews C, Chan WM, McKeown CA, Magli A, de Berardinis T,Loewenstein A, Lazar M, O'Keefe M, Letson R, London A, Ruttum M, Matsumoto N,Saito N, Morris L, Del Monte M, Johnson RH, Uyama E, Houtman WA, de Vries B,Carlow TJ, Hart BL, Krawiecki N, Shoffner J, Vogel MC, Katowitz J, Goldstein SM, Levin AV, Sener EC, Ozturk BT, Akarsu AN, Brodsky MC, Hanisch F, Cruse RP, ZubcovAA, Robb RM, Roggenkäemper P, Gottlob I, Kowal L, Battu R, Traboulsi EI,Franceschini P, Newlin A, Demer JL, Engle EC. Heterozygous mutations of thekinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1).Nat Genet. 2003 Dec;35(4):318-21.
  13. Yamada K, Chan WM, Andrews C, Bosley TM, Sener EC, Zwaan JT, Mullaney PB,Oztürk BT, Akarsu AN, Sabol LJ, Demer JL, Sullivan TJ, Gottlob I, RoggenkäemperP, Mackey DA, De Uzcategui CE, Uzcategui N, Ben-Zeev B, Traboulsi EI, Magli A, deBerardinis T, Gagliardi V, Awasthi-Patney S, Vogel MC, Rizzo JF 3rd, Engle EC.Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3). Invest Ophthalmol Vis Sci. 2004Jul;45(7):2218-23.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 384
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 04 Jan 2021